University Hospitals

Axuall, Inc. is a workforce intelligence company that operates a digital network designed to verify identities, credentials, and authenticity across various sectors, including healthcare, insurance, and logistics. Founded in 2018 and based in Cleveland, Ohio, Axuall offers an integrated platform that facilitates smarter decision-making and expedites the onboarding process for healthcare providers. By leveraging real-time practitioner data, the company enhances workforce deployment and efficiency, and provides critical insights for network planning, analytics, and reporting. Its solutions aim to empower healthcare professionals by granting them control over their career identities while connecting health systems, staffing firms, and telehealth organizations to valuable data resources.

BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and Development. The Harrington Project, unveiled in February by University Hospitals (UH), is a first-of-its-kind $250 million initiative that promises to revolutionize how new breakthrough drugs are advanced to market. By aligning the upstream efforts of the recently created UH Case Medical Center’s Harrington Discovery Institute with the downstream development efforts of BioMotiv, The Harrington Project seeks to accelerate the therapeutic innovation process for the benefit of patients globally. The company was founded in 2012 and is headquartered in Cleveland, Ohio.

BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and Development. The Harrington Project, unveiled in February by University Hospitals (UH), is a first-of-its-kind $250 million initiative that promises to revolutionize how new breakthrough drugs are advanced to market. By aligning the upstream efforts of the recently created UH Case Medical Center’s Harrington Discovery Institute with the downstream development efforts of BioMotiv, The Harrington Project seeks to accelerate the therapeutic innovation process for the benefit of patients globally. The company was founded in 2012 and is headquartered in Cleveland, Ohio.